Orbimed Advisors - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$91,753,755
-16.3%
3,968,588
-5.0%
1.95%
-1.8%
Q2 2023$109,562,577
-5.4%
4,178,588
-7.1%
1.98%
-12.7%
Q1 2023$115,801,686
-15.2%
4,498,900
-14.3%
2.27%
-13.0%
Q4 2022$136,552,500
-13.4%
5,250,000
-5.0%
2.61%
-10.8%
Q3 2022$157,655,000
+6.2%
5,525,926
-8.3%
2.93%
+8.9%
Q2 2022$148,417,000
-56.4%
6,028,3070.0%2.69%
-51.3%
Q1 2022$340,238,000
-8.9%
6,028,3070.0%5.52%
+14.9%
Q4 2021$373,634,000
-2.3%
6,028,3070.0%4.80%
+14.3%
Q3 2021$382,436,000
-23.2%
6,028,307
-0.3%
4.20%
-16.6%
Q2 2021$498,108,000
+9.4%
6,044,266
-2.3%
5.04%
+18.4%
Q1 2021$455,127,000
-15.3%
6,186,307
-16.5%
4.26%
-9.4%
Q4 2020$537,105,000
+52.1%
7,406,3070.0%4.70%
+5.9%
Q3 2020$353,059,000
+13.5%
7,406,3070.0%4.44%
+1.3%
Q2 2020$311,065,000
+55.6%
7,406,3070.0%4.38%
+30.3%
Q1 2020$199,970,000
-29.9%
7,406,3070.0%3.36%
-17.4%
Q4 2019$285,069,000
+77.5%
7,406,3070.0%4.07%
+33.6%
Q3 2019$160,569,0007,406,3073.05%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$429,009,00024.30%
Consonance Capital Management LP 1,201,399$88,387,0009.42%
Boxer Capital, LLC 2,075,905$152,724,0005.18%
Perceptive Advisors 4,849,912$356,808,0004.51%
Orbimed Advisors 6,186,307$455,127,0004.26%
Samsara BioCapital, LLC 169,852$12,496,0002.30%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,262,075$92,851,0001.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$41,094,0000.86%
SPHERA FUNDS MANAGEMENT LTD. 137,672$10,129,0000.78%
Affinity Asset Advisors, LLC 27,000$1,986,0000.67%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders